Drugs / OXA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03279614 | Sep 2017 → Sep 2019 | neuroendocrine carcinoma | Peking University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OXA | “OXA：130mg/m2 ，iv drip for 180min d1” NCT03279614 ↗ |
| Route | Intravenous | “iv drip” NCT03279614 ↗ |